Moderna shares surge after U.S. FDA to consider its flu shot

Published:

Moderna shares surge after U.S. FDA to consider its flu shot
Photo: Leon Neal/AP

The Swedish Medicines Agency has previously rejected Moderna's application to test the vaccine. The vaccine is an mRNA vaccine, and Moderna is seeking full approval to offer the vaccine to adults aged 50 to 64.

Loading related articles...

Tags

Author

TT News AgencyT
By TT News AgencyEnglish edition by Sweden Herald, adapted for our readers

Keep reading

Loading related posts...